Download as pdf or txt
Download as pdf or txt
You are on page 1of 44

DH308: NIRMAL PUNJABI

DH 308 – Class 2
06th January 2023

Clinical Data
Management
- Nirmal Punjabi, Ph.D.

Welcome to the course. We will start at 11:05 am.


DH308: NIRMAL PUNJABI

Today’s Agenda (Class 2)


• Revisit Class 1 Class 2:
• Introduction to Clinical Data • Background
Management • Clinical Trials
• Course Logistics • Types
• Purpose
• Time line
• Size of the cohort
• Control
• Some Terms
• Examples

• Vital Parameters

10-01-2023 2
DH308: NIRMAL PUNJABI

Introduction to
Clinical Data Management
DH308: NIRMAL PUNJABI

Etymology of Course Name

CLINICAL DATA MANAGEMENT

10-01-2023 4
DH308: NIRMAL PUNJABI

Introduction to Clinical Data Management

Clinical Data Management

“Management of Clinical Data”


Clinical Data Management= Clinical Data + Data Management
5
10-01-2023 Image Ref: https://ocrc.net/; Wikipedia ‘Data’; https://trendythingy.in/
DH308: NIRMAL PUNJABI

Clinical Data
Sources, Types, Significance
DH308: NIRMAL PUNJABI

Clinical Data
• Data generated from Clinical Research/Studies/Trials

• Clinical Research
• Patient-oriented research

10-01-2023 Source: US FDA 7


DH308: NIRMAL PUNJABI

Clinical Research
• To understand the effect of drug
/ medicine / vaccine
• New
• Repurposing

• To check the effectiveness of


medical device.
• Diagnosis
• Treatment
• Functional

10-01-2023 8
Image Reference: Volkmann et al, 2020. https://doi.org/10.1371/journal.pone.0241497; https://neuralink.com/approach/
DH308: NIRMAL PUNJABI

Clinical Research
• Validation of diagnostic tests

• To understand the mechanism


of disease progression.

10-01-2023 Image Reference: https://breathonix.com/; : Hosseini et al, DOI: https://doi.org/10.1016/j.virol.2020.08.011 Virology, 2020 9
DH308: NIRMAL PUNJABI

Clinical Research
• Preclinical (in vitro)

• Preclinical (in vivo)

• Clinical Trials

• Exclusions:
• Only on tissues/organ in vitro and
without mapping it to patient.

10-01-2023 10
Image Reference: Dobrovolskaia, 2013; https://doi.org/10.1016/j.jconrel.2013.05.025
DH308: NIRMAL PUNJABI

Clinical Trials (Phases)

10-01-2023 11
Image Reference: https://lupustrials.org/about-trials/phases-of-a-trial/
DH308: NIRMAL PUNJABI

Examples of Clinical Trials

• WHO's Solidarity Plus trial


• 52 countries involved (as
of 2nd January 2023)
• 14200 hospitalized
patients
• 600 hospitals
• 2000 researchers
• Total : 7 drugs (4
repurposed & 3 now)

10-01-2023 Image Reference: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-


for-covid-19-treatments
12
DH308: NIRMAL PUNJABI

Examples of Clinical Trials


• Recovery Trial
• 48348 Participants (as of 3rd January 2023)
• 200 sites in UK & some international sites
• Testing treatments for COVID-19 and Influenza

• The RECOVERY Trial is registered at ISRCTN50189673


• EU Clinical Trials Register: EudraCT 2020-001113-21
• Clinical Trials.gov: NCT04381936

• Randomised, Embedded, Multifactorial Adaptive Platform Trial for


Community-Acquired Pneumonia (REMAP-CAP; NCT02735707)
• 10000 participants (estimated as on 3rd January 2023)

10-01-2023 13
DH308: NIRMAL PUNJABI

Clinical Data Types/Sources


Basic
Parameters

Other
Clinical
Pathology
medical
instruments
Data Tests

Source

Medical
Imaging

10-01-2023 14
DH308: NIRMAL PUNJABI

Conventional: Case Report Forms (Paper


forms)

10-01-2023 Image Reference: https://stoptb.org/wg/new_diagnostics/assets/documents/case-report-form.pdf 15


DH308: NIRMAL PUNJABI

Challenges with Clinical Data


• Large data sets

• Interdependent parameters

• Confounding factors

10-01-2023 Image Reference: https://www.theverge.com/2020/10/5/21502141/uk-missing-coronavirus-cases-excel-spreadsheet-error 16


DH308: NIRMAL PUNJABI

Challenges with Clinical Data


• Large data sets

• Interdependent parameters

• Confounding factors

• Long life cycle

10-01-2023 Image Reference: https://pubmed.ncbi.nlm.nih.gov/32450107/ 17


DH308: NIRMAL PUNJABI

Generation / Collection
Representation
Formatting
Documentation
Data Quality Control
Life-Cycle Transformation
Access and sharing
Security & Back-up
Archiving

10-01-2023 18
DH308: NIRMAL PUNJABI

Clinical Data Management


Clinical Data + Data Management

10-01-2023 19
DH308: NIRMAL PUNJABI

Clinical Data Management


• Data Planning
• Case report form (CRF) design,
• Clinical trials database design and programming
• Data standards,
• Data acquisition,
• Data integration into the clinical trials database,
• Data review for quality control
• Database creation and maintenance
• Regulations
• Audit trails

10-01-2023 20
DH308: NIRMAL PUNJABI

Clinical Data Management

10-01-2023 21
Image Reference: https://www.healthcatalyst.com/insights/5-reasons-healthcare-data-is-difficult-to-measure
DH308: NIRMAL PUNJABI

Standard Tools for Clinical Research Data


Capture

10-01-2023 22
DH308: NIRMAL PUNJABI

Objective of the course


• Overview of the domain of Clinical Data Management
• Why is it needed?
• Where is it applicable?

• Provide understanding of the process of Clinical Data Management


• Study Startup
• Study Conduct
• Study Close Out

10-01-2023 23
DH308: NIRMAL PUNJABI

Course Contents
• Background: Clinical Trials, Technical Terms, Medical Data Types
• Different Domains
Section 1 • Clinical Trials
• Medical Terms
• Study Start up - Data Planning: Hypothesis, Validated Instruments, CRF • Planning
design, eCRF design, Defining codes/rules, SOPs; Building / selecting
Section 2 databases, Testing Databases • Research Planning
• Human Factors Design
• Study Conduct: Data retrieving, Data cleaning, Documentation of Adverse • Protocols
events,
Section 3 • Error mitigation
• Database selection
• Study Close Out: Data validation & lock, Send for Analysis
• Data-types
Section 4 • Regulations in Practice
• HIPAA
• Future application: Role of AI/ML in clinical trials
• CFR 21, 11
Section 5 • Bio-statistics
10-01-2023 24
DH308: NIRMAL PUNJABI

Pre-requisites
• None
• Ready to catch up with new jargons across domains
• Data collection tools/forms

• Good to know:
• Basic understanding of common health parameters (Blood pressure, Heart
rate, etc.)
• Basic understanding of medical data from X-Ray, CT scan, ECG,

10-01-2023 25
DH308: NIRMAL PUNJABI

Grading system *
• Assignments (Individual): 15 % • For Audit:
• ≥ 50% score in Assignments, Quiz,
• Quiz: 10 % Course Project, and Mid-Sem
• Course Project/Group Assignment: • End-Sem is optional
20 %
• Mid-Sem: 25%
• End-Sem: 30 %

• Attendance/Class interaction
• Attendance/Class interaction (expected): ≥ 70%
(expected): ≥ 70%
10-01-2023 26
* Tentative
DH308: NIRMAL PUNJABI

Microsoft Teams for communication


• For Assignments / Online class / Discussions / Updates

• Teams code to join ‘DH308 Clinical Data Management 2023’

Code: tee4jwj

10-01-2023 27
DH308: NIRMAL PUNJABI

Class Schedule for January


• Wednesday and Friday: 11:05am to 12:30 pm

• Exception:
• 20th January (Friday) : No class
• 21st January (Saturday): 11:05 am to 12:30 pm.

10-01-2023 28
DH308: NIRMAL PUNJABI

Discussion / Doubts / Ideas / Feedback session


• Every Alternate Saturday from 11 am to 12 noon
• Optional & Online on Teams

• Schedule for January


• 7th January 2023 (Tomorrow)
• 28th January 2023

• In-person meeting:
• E-mail me (npunjabi@iitb.ac.in) to schedule.
• Schedule for January:
• 7th January
10-01-2023 • 21st January 29
DH308: NIRMAL PUNJABI

Clinical Trials
Background: Phases, Types, ….

10-01-2023 30
DH308: NIRMAL PUNJABI

Clinical Trials
• Research involving human subjects.
• “A prospectively planned experiment for the purpose of evaluating
potentially beneficial therapies or treatments”

• Any research:
• that prospectively assigns participants/groups (humans),
• to one or more health related interventions,
• to evaluate the effect on health outcomes.

10-01-2023 31
DH308: NIRMAL PUNJABI

Clinical Trials (…)

• Types
• Observative
• Prospective
• Retrospective

• Intervention
• New treatment/medicine/
• New medical device

10-01-2023 32
DH308: NIRMAL PUNJABI

Clinical Trials
• Controlled Conditions
• Participants
• Age Group
• Sex
• Ethnicity
• Present Health Status
• Diet
• Medical History

10-01-2023 33
DH308: NIRMAL PUNJABI

Clinical Trials
• Controlled Conditions
• Site / Location
• Environmental
conditions

• Types:
• Single Site
• Multi-Site
• Hospitals
• Regional
• State
• Country

10-01-2023 34
DH308: NIRMAL PUNJABI

Clinical Trials
• Controlled Conditions
• Intervention /Therapy
• Investigational Drug

• Control
• Gold standard /
Conventional
• Placebo

10-01-2023 Image Reference: Volkmann et al, 2020. https://doi.org/10.1371/journal.pone.0241497; 35


DH308: NIRMAL PUNJABI

Types of Study Designs

1. Observational Designs

1. Experimental Designs – interventional studies


DH308: NIRMAL PUNJABI

Types of Study Designs

1. Observational Designs
DH308: NIRMAL PUNJABI

Types of Observational Studies


• Cohort Studies
• A group of subjects followed over time
• Purpose: defining the incidence and investigating potential causes of a
condition (incidence)
• Can be prospective – investigator chooses a sample group and measures
characteristics in each subject over a period of time that might predict
outcomes
• Can be retrospective – same as prospective, except all data collection and
follow-up has happened in the past; only possible if adequate data is available
DH308: NIRMAL PUNJABI

Types of Observational Studies


• Cross-Sectional Studies
• Similar to cohort studies except all the measurements are made at one time
point with no follow-up
• Purpose: describing variables and their distribution patterns (prevalence)
• Strength – fast and inexpensive since there is no follow-up or waiting time for
outcome
DH308: NIRMAL PUNJABI

Types of Observational Studies


• Case-Control Studies
• Two groups of people examined for the same outcome
• Group 1 – “cases” or a population of people with a certain disease
• Group 2 – “controls” or a population of people without that same disease
• Purpose: compare prevalence of risk factor(s) in subjects with the disease
(cases) versus subjects without the disease (controls)
DH308: NIRMAL PUNJABI

Types of Study Designs

1. Experimental Designs
DH308: NIRMAL PUNJABI

Experimental Studies
• These studies evaluate the effects of an intervention
• Types of interventions:
• Behavior modification (eg. a walking program to improve weight loss)
• Drug (eg. a new investigational drug or studying a drug for off-label use – subject to FDA
regulations)
• Device (eg. a new investigational stent – subject to FDA regulations)
• Strength: Can demonstrate causality
DH308: NIRMAL PUNJABI

Phases of Experimental Studies


DH308: NIRMAL PUNJABI

Phases of Experimental Studies


• Phase – 0
• First in human trial.
• Purpose is to streamline drug approval process.
• Target/biomarker analytical assays.
• Limited number of subjects (n < 15).
• Exposure to low & non‐toxic doses of the drug for a limited duration (≤ 7 days)
• Provide human PK/PD data.
• Pharmacokinetic : Absorption, Distribution, Metabolism, and excretion
• Pharmacodynamic: Biological processes respond to impacted by drug
• No therapeutic benefit to the participants.

You might also like